These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

878 related items for PubMed ID: 16772018

  • 1. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors.
    Hladik W, Kataaha P, Mermin J, Purdy M, Otekat G, Lackritz E, Alter MJ, Downing R.
    Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of hepatitis C virus antibodies and genotypes in asymptomatic, first-time blood donors in Namibia.
    Vardas E, Sitas F, Seidel K, Casteling A, Sim J.
    Bull World Health Organ; 1999 Jun; 77(12):965-72. PubMed ID: 10680243
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.
    Nantachit N, Thaikruea L, Thongsawat S, Leetrakool N, Fongsatikul L, Sompan P, Fong YL, Nichols D, Ziermann R, Ness P, Nelson KE.
    Transfusion; 2007 Oct; 47(10):1803-8. PubMed ID: 17880604
    [Abstract] [Full Text] [Related]

  • 4. Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors.
    Ren FR, Lv QS, Zhuang H, Li JJ, Gong XY, Gao GJ, Liu CL, Wang JX, Yao FZ, Zheng YR, Zhu FM, Tiemuer MH, Bai XH, Shan H.
    Transfusion; 2005 Nov; 45(11):1816-22. PubMed ID: 16271110
    [Abstract] [Full Text] [Related]

  • 5. Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms.
    Kleinman SH, Stramer SL, Brodsky JP, Caglioti S, Busch MP.
    Transfusion; 2006 May; 46(5):695-702. PubMed ID: 16686836
    [Abstract] [Full Text] [Related]

  • 6. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
    Conry-Cantilena C, VanRaden M, Gibble J, Melpolder J, Shakil AO, Viladomiu L, Cheung L, DiBisceglie A, Hoofnagle J, Shih JW.
    N Engl J Med; 1996 Jun 27; 334(26):1691-6. PubMed ID: 8637513
    [Abstract] [Full Text] [Related]

  • 7. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, Le Roux M, Kuun E, Gulube S, Reddy R.
    Transfusion; 2009 Jun 27; 49(6):1115-25. PubMed ID: 19309474
    [Abstract] [Full Text] [Related]

  • 8. Prevalence, severity, and risk factors of liver disease in blood donors positive in a second-generation anti-hepatitis C virus screening test.
    Serfaty L, Nousbaum JB, Elghouzzi MH, Giral P, Legendre C, Poupon R.
    Hepatology; 1995 Mar 27; 21(3):725-9. PubMed ID: 7875670
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania.
    Matee MI, Lyamuya EF, Mbena EC, Magessa PM, Sufi J, Marwa GJ, Mwasulama OJ, Mbwana J.
    East Afr Med J; 1999 Mar 27; 76(3):167-71. PubMed ID: 10442119
    [Abstract] [Full Text] [Related]

  • 10. Performance of hepatitis C virus (HCV) antibody test systems in relation to HCV-RNA detection in the diagnosis of HCV infection.
    Krarup HB, Jacobsen SE, Varming K, Drewes AM, Madsen PH.
    Dan Med Bull; 1998 Feb 27; 45(1):89-91. PubMed ID: 9504268
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR, Mathur A, Mathur D, Udawat HP, Nepalia S, Nijhawan S, Mathur A.
    Trop Gastroenterol; 2007 Feb 27; 28(1):19-23. PubMed ID: 17896605
    [Abstract] [Full Text] [Related]

  • 12. Serologic and molecular typing of human T-lymphotropic virus among blood donors in Maputo City, Mozambique.
    Gudo ES, Abreu CM, Mussá T, Augusto Ado R, Otsuki K, Chambo E, Amade N, Tanuri A, Ferreira OC, Jani IV, HTLV in Mozambique Study Group.
    Transfusion; 2009 Jun 27; 49(6):1146-50. PubMed ID: 19222818
    [Abstract] [Full Text] [Related]

  • 13. Hepatitis C seroprevalence in accepted versus deferred blood-donor candidates evaluated by medical history and self-exclusion form.
    López RA, Romero-Estrella S, Infante-Ramírez L, Méndez-Aquino JS, Berrón-Ruiz P, Morales-Alfaro NA, Vivar R, Carrada E, Rivera-Rendón Mdel R, Sánchez-Guerrero SA.
    Transfusion; 2004 Sep 27; 44(9):1344-9. PubMed ID: 15318859
    [Abstract] [Full Text] [Related]

  • 14. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C, Romanò L, Fomiatti L, Baruffi L, Zanetti AR, SIMTI Research Group.
    Transfusion; 2008 Oct 27; 48(10):2205-13. PubMed ID: 18631163
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
    Wang JT, Wang TH, Sheu JC, Tsai SJ, Hsieh YS, Lin DT, Wang CY, Chen DS.
    Arch Pathol Lab Med; 1993 Feb 27; 117(2):152-6. PubMed ID: 8381269
    [Abstract] [Full Text] [Related]

  • 16. A study on the epidemiology of hepatitis C infection among blood donors in Singapore.
    Wang JE.
    J Public Health Med; 1995 Dec 27; 17(4):387-91. PubMed ID: 8639336
    [Abstract] [Full Text] [Related]

  • 17. Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infection.
    Nübling CM, Chudy M, Volkers P, Löwer J.
    Transfusion; 2006 Nov 27; 46(11):1886-91. PubMed ID: 17076842
    [Abstract] [Full Text] [Related]

  • 18. The significance of repeat testing in Turkish blood donors screened with HBV, HCV and HIV immunoassays and the importance of S/CO ratios in the interpretation of HCV/HIV screening test results and as a determinant for further confirmatory testing.
    Acar A, Kemahli S, Altunay H, Kosan E, Oncul O, Gorenek L, Cavuslu S.
    Transfus Med; 2010 Jun 27; 20(3):152-9. PubMed ID: 20059750
    [Abstract] [Full Text] [Related]

  • 19. Effect of preventive applications on prevalence of hepatitis B virus and hepatitis C virus infections in West Turkey.
    Sakarya S, Oncu S, Ozturk B, Oncu S.
    Saudi Med J; 2004 Aug 27; 25(8):1070-2. PubMed ID: 15322600
    [Abstract] [Full Text] [Related]

  • 20. HIV, HCV, HBV and syphilis rate of positive donations among blood donations in Mali: lower rates among volunteer blood donors.
    Diarra A, Kouriba B, Baby M, Murphy E, Lefrere JJ.
    Transfus Clin Biol; 2009 Aug 27; 16(5-6):444-7. PubMed ID: 19896404
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.